Published in Virchows Arch on January 30, 2014
[Precursors of gastric cancer : Dysplasia and adenoma]. Pathologe (2017) 0.89
Interobserver and intraobserver agreement for gastric mucosa atrophy. BMC Gastroenterol (2015) 0.82
High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA. Dig Dis Sci (2015) 0.78
Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut (2016) 0.77
Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol (2016) 0.77
Gastritis - facts and doubts. Prz Gastroenterol (2016) 0.75
Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol (2016) 0.75
[Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems]. Pan Afr Med J (2016) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57
Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology (2010) 2.02
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc (2010) 1.46
Staging gastritis: an international proposal. Gastroenterology (2005) 1.29
Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol (2000) 1.24
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther (2010) 1.15
Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol (1999) 1.14
Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol (2012) 1.09
Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol (2011) 1.03
Gastritis: the histology report. Dig Liver Dis (2011) 1.02
Observer agreement on the grading of gastric atrophy. Histopathology (1999) 1.01
Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol (1999) 1.01
Atrophic gastritis: pathology and endoscopy in the reversibility assessment. Gut (2003) 0.98
First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther (2012) 0.93
Assessment of atrophic gastritis using the OLGA system. Helicobacter (2008) 0.86
How to assess the severity of atrophic gastritis. World J Gastroenterol (2011) 0.83
Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol (2013) 0.81
The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol (2001) 0.78
[The Russian revision of chronic gastritis classification: reproducibility of the pathomorphologic picture]. Arkh Patol (2011) 0.75
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol (2010) 1.52
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Ultrasensitive silicon nanowire for real-world gas sensing: noninvasive diagnosis of cancer from breath volatolome. Nano Lett (2014) 1.09
The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci (2009) 0.96
An unusual case of bleeding from stomach due to a giant diospyrobezoar. Medicina (Kaunas) (2009) 0.88
Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg (2010) 0.87
Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection. FEMS Immunol Med Microbiol (2005) 0.85
Replication study of ulcerative colitis risk loci in a Lithuanian-Latvian case-control sample. Inflamm Bowel Dis (2013) 0.85
Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin. FEMS Immunol Med Microbiol (2007) 0.84
Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use. Eur J Gastroenterol Hepatol (2015) 0.83
The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia: do we still need histology to select individuals at risk for adenocarcinoma? Eur J Gastroenterol Hepatol (2014) 0.83
Helicobacter pylori infection in laryngeal diseases. Eur Arch Otorhinolaryngol (2013) 0.81
Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol (2013) 0.81
Geographical variation in the exhaled volatile organic compounds. J Breath Res (2013) 0.81
Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol (2012) 0.81
Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients. Medicina (Kaunas) (2007) 0.81
Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol (2013) 0.81
Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer. Asian Pac J Cancer Prev (2015) 0.81
Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients. Fam Cancer (2013) 0.79
Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol (2011) 0.79
Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions. Eur J Cancer (2010) 0.77
The effect of incisura angularis biopsy sampling on the assessment of gastritis stage. Eur J Gastroenterol Hepatol (2014) 0.77
Analysis of the effects of microbiome-related confounding factors on the reproducibility of the volatolomic test. J Breath Res (2016) 0.77
Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. J Gastrointestin Liver Dis (2011) 0.76
Management of Helicobacter pylori-related diseases in the Baltic States. Dig Dis (2014) 0.75
Prevalence, Clinical Characteristics, and Risk Factors for Non-recording of Alcohol Use in Hospitals across Europe: The ALCHIMIE Study. Alcohol Alcohol (2016) 0.75
[Diagnosis and management of 46,XY mixed gonadal dysgenesis and disorder of sexual differentiation]. Medicina (Kaunas) (2009) 0.75
Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations - a randomized trial in Latvia. Eur J Gastroenterol Hepatol (2016) 0.75
Microvillous inclusion disease. Medicina (Kaunas) (2004) 0.75
Helicobacter pylori and non-malignant diseases. Helicobacter (2008) 0.75
Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (2015) 0.75